Introduction
============

*Candida*airway colonization is common in mechanically ventilated ICU patients. Its significance and impact on outcomes are not well defined. We aimed to describe *Candida*airway colonization and assess clinical outcomes of patients with a clinical suspicion of ventilator-associated pneumonia (VAP) colonized with *Candida*.

Methods
=======

A retrospective post-hoc analysis of the prospective, multicentre VAP study, which enrolled patients with a clinical suspicion of VAP, admitted to an ICU for \> 96 hours and on mechanical ventilation (MV) for \> 48 hours. Airway cultures were done on randomization. Patients with positive *Candida*cultures from other sites were excluded. The remaining patients were divided into two groups according to their *Candida*airway culture status. Demographics, admission diagnosis, comorbidities, PaO~2~/FiO~2~ratio and APACHE II score were recorded at randomization. The length of MV, ICU and hospital stay were compared, as well as hospital, ICU and 28-day mortality. Appropriate parametric statistical tests were applied according to data.

Results
=======

Of the 739 patients enrolled in the VAP study, 639 were included for analysis: 114 had *Candida*airway colonization (C) and 525 did not (NC). No significant differences were noted in demographics and APACHE II score (20 ± 6 vs 20 ± 6, *P*= 0.37) except more frequent admission for sepsis (7.0% vs 2.1%, *P*= 0.005) and respiratory conditions (21.9% vs 14.3%, *P*= 0.04) in group C. More colonized patients were on antibiotics at randomization (81.6% vs 56.7%, *P*\< 0.001). A trend for increased ICU (21.1% vs 13.9%, *P*= 0.06) and 28-day mortality (23.7% vs 16.4%, *P*= 0.08) and a significant difference in hospital mortality (34.2% vs 21.1%, *P*= 0.003) was observed in group C. A trend was found for increased median length of ICU stay (14.1 vs 11.6 days, *P*= 0.07) and duration of MV (10.9 vs 8.1, *P*= 0.06). Hospital stay was significantly longer (59.9 vs 38.6 days, *P*= 0.006) in group C.

Conclusion
==========

Respiratory tract *Candida*colonization in patients with clinical suspicion of VAP is associated with an increased burden of illness. Whether *Candida*colonization is responsible for worse outcomes remains to be established.
